Synthesis, antioxidant and carbonic anhydrase I and II inhibitory activities of novel sulphonamide-substituted coumarylthiazole derivatives

References

• Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–81
   PubMed Web of Science ®Google Scholar
• Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 2011;10:767–77
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibitors and activators for novel therapeutic applications. Future Med Chem 2011;3:1165–80
   PubMed Web of Science ®Google Scholar
• Supuran CT. Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2012;27:759–72
   PubMed Web of Science ®Google Scholar
• Monti SM, Maresca A, Viparelli F, et al. Dithiocarbamates are strong inhibitors of the beta-class fungal carbonic anhydrases from Cryptococcus neoformans, Candida albicans and Candida glabrata. Bioorg Med Chem Lett 2012;22:859–62
   PubMed Web of Science ®Google Scholar
• D'Ambrosio K, Smaine FZ, Carta F, et al. Development of potent carbonic anhydrase inhibitors incorporating both sulfonamide and sulfamide groups. J Med Chem 2012;55:6776–83
   PubMed Web of Science ®Google Scholar
• Vullo D, Kupriyanova EV, Scozzafava A, et al. Anion inhibition study of the β-carbonic anhydrase (CahB1) from the cyanobacterium Coleofasciculus chthonoplastes (ex-Microcoleus chthonoplastes). Bioorg Med Chem 2014;22:1667–71
   PubMed Web of Science ®Google Scholar
• Prete SD, Vullo D, Fisher GM, et al. Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum-the η-carbonic anhydrases. Bioorg Med Chem Lett 2014;24:4389–96
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A. Carbonic anhydrases as targets for medicinal chemistry. Bioorg Med Chem 2007;15:4336–50
   PubMed Web of Science ®Google Scholar
• Husain A, Madhesia D. Heterocyclic compounds as carbonic anhydrase inhibitor. J Enzyme Inhib Med Chem 2012;27:773–83
   PubMed Web of Science ®Google Scholar
• Gao BB, Clermont A, Rook S, et al. Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrean activation. Nat Med 2007;13:181–8
   PubMed Web of Science ®Google Scholar
• Alterio V, Di Fiore A, D'Ambrosio K, et al. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms. Chem Rev 2012;112:4421–68
   PubMed Web of Science ®Google Scholar
• Poulsen SA. Carbonic anhydrase inhibition as a cancer therapy: a review of patent literature, 2007–2009. Exp Opin Ther Pat 2010;20:795–806
   PubMed Web of Science ®Google Scholar
• Krall N, Pretto F, Decurtins W, et al. A small-molecule drug conjugate for the treatment of carbonic anhydrase IX expressing tumors. Angew Chem Int Ed 2014;53;4231–5
   PubMed Web of Science ®Google Scholar
• Congiu C, Onnis V, Balboni G, Supuran CT. Synthesis and carbonic anhydrase I, II, IX and XII inhibition studies of 4-N,N-disubstituted sulfanilamides incorporating 4,4,4-trifluoro-3-oxo-but-1-enyl, phenacylthiourea and imidazol-2(3H)-one/thione moieties. Bioorg Med Chem Lett 2014;24:1776–9
   PubMed Web of Science ®Google Scholar
• Durdagi S, Senturk M, Ekinci D, et al. Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site. Bioorg Med Chem 2011;19:1381–9
   PubMed Web of Science ®Google Scholar
• De Simone G, Alterio V, Supuran CT. Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors. Expert Opin Drug Discov 2013;8:793–810
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibitors: an editorial. Expert Opin Ther Pat 2013;23:677–9
   PubMed Web of Science ®Google Scholar
• Aggarwal M, Kondeti B, McKenna R. Anticonvulsant/antiepileptic carbonic anhydrase inhibitors: a patent review. Expert Opin Ther Pat 2013;23:717–24
   PubMed Web of Science ®Google Scholar
• Liu F, Martin-Mingot A, Lecornué F, et al. Carbonic Anhydrases inhibitory effects of new benzenesulfonamides synthesized by using superacid chemistry. J Enzyme Inhib Med Chem 2012;27:886–91
   PubMed Web of Science ®Google Scholar
• Metayer B, Mingot A, Vullo D, et al. New superacid synthesized (fluorinated) tertiary benzenesulfonamides acting as selective hCA IX inhibitors: toward a new mode of carbonic anhydrase inhibition by sulphonamides. Chem Commun 2013;49:6015–17
   PubMed Web of Science ®Google Scholar
• Metayer B, Martin-Mingot A, Vullo D, et al. Superacid synthesized tertiary benzenesulfonamides and benzofuzed sultams act as selective hCA IX inhibitors: toward understanding a new mode of inhibition by tertiary sulphonamides. Org Biomol Chem 2013;11:7540–9
   PubMed Web of Science ®Google Scholar
• Supuran CT, Winum JY. Selectivity issues in the design of CA inhibitors. Drug design of zinc-enzyme inhibitors: functional, structural, and disease applications. Vol. 13. New Jersey: John Wiley & Sons; 2009. p. 473
   Google Scholar
• Guler OO, De Simone G, Supuran CT. Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII. Curr Med Chem 2010;17:1516–26
   PubMed Web of Science ®Google Scholar
• Kontogiorgis C, Detsi A, Hadjipavlou-Litina D. Coumarin-based drugs: a patent review (2008–present). Expert Opin Ther Pat 2012;22:437–54
   PubMed Web of Science ®Google Scholar
• Kumar A, Gupta MK, Kumar M. An efficient non-ionic surfactant catalysed multicomponent synthesis of novel Benzylamino coumarin derivative via Mannich type reaction in water. Tetrahedron Lett 2011;52:4521–5
   Web of Science ®Google Scholar
• Parvez A, Meshram J, Tiwari V, et al. Pharmacophores modeling in terms of prediction of theoretical physico-chemical properties and verification by experimental correlations of novel coumarin derivatives produced via Betti's protocol. Eur J Med Chem 2010;45:4370–8
   PubMed Web of Science ®Google Scholar
• Maresca A, Temperini C, Vu H, et al. Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors. J Am Chem Soc 2009;131:3057–62
   PubMed Web of Science ®Google Scholar
• Maresca A, Temperini C, Pochet L, et al. Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins. J Med Chem 2010;53:335–44
   PubMed Web of Science ®Google Scholar
• Carta F, Maresca A, Scozzafava A, Supuran CT. Novel coumarins and 2-thioxo-coumarins as inhibitors of the tumor-associated carbonic anhydrases IX and XII. Bioorg Med Chem 2012;20:2266–73
   PubMed Web of Science ®Google Scholar
• Tars K, Vullo D, Kazaks A, et al. Sulfocoumarins (1,2-benzoxathiine-2,2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases. J Med Chem 2013;56:293–300
   PubMed Web of Science ®Google Scholar
• Karade N, Gampawar SN, Shinde SV, Jadhav WN. L-Proline catalyzed solvent-free Knoevenagel condensation for the synthesis of 3-substituted coumarins. Chinese J Chem 2007;25:1686–9
   Web of Science ®Google Scholar
• Koelsch CF. Bromination of 3-acetocoumarin. J Am Chem Soc 1950;72:2993–5
   Web of Science ®Google Scholar
• Zhuravel OI, Kovalenko SM, Vlasov SV, Chernykh VP. Solution-phase synthesis of a combinatorial library of 3-[4-(coumarin-3-yl)-1,3-thiazol-2-ylcarbamoyl]propanoic acid amides. Molecules 2005;10:444–56
   PubMed Web of Science ®Google Scholar
• Arslan O, Nalbantoglu B, Demir N, et al. A new method for the purification of carbonic anhydrase isozymes by affinity choromatography. Turk J Med Sci 1996;26:163–6
   Google Scholar
• Maren TH. A simplified micromethod for the determination of carbonic anhydrase and its inhibitors. J Pharm Exp Ther 1960;130:2629–34
   Web of Science ®Google Scholar
• Re R, Pellegrini N, Proteggente A, et al. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radical Bio Med 1999;26:1231–7
   PubMed Web of Science ®Google Scholar
• Apak R, Guclu K, Ozyurek M, Karademir SE. Novel total antioxidant capacity index for dietary polyphenols and vitamins C and E, using their cupric ion reducing capability in the presence of neocuproine: CUPRAC method. J Agr Food Chem 2004;52:7970–81
   PubMed Web of Science ®Google Scholar
• Kurt BZ, Gazioglu I, Sonmez F, Kucukislamoglu M. Synthesis, antioxidant and anticholinesterase activities of novel coumarylthiazole derivatives. Bioorg Chem 2015; 59:80–90
   PubMed Web of Science ®Google Scholar
• Grandane A, Tanc M, Zalubovskis R, Supuran CT. 6-Triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrases IX and XII. Bioorg Med Chem Lett 2014;24:1256–60
   PubMed Web of Science ®Google Scholar
• Maresca A, Scozzafava A, Supuran CT. 7,8-Disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II in the low nanomolar/subnanomolar range. Bioorg Med Chem Lett 2010;20:7255–8
   PubMed Web of Science ®Google Scholar
• Wagner J, Avvaru BS, Robbins AH, et al. Coumarinyl-substituted sulfonamides strongly inhibit several human carbonic anhydrase isoforms: solution and crystallographic investigations. Bioorg Med Chem 2010;18:4873–8
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Arylsulfonylureido- and arylureido-substituted aromatic and heterocyclic sulfonamides: towards selective inhibitors of carbonic anhydrase isozyme I. J Enzyme Inhib Med Chem 1999;14:343–63
   Web of Science ®Google Scholar
• Pacchiano F, Carta F, McDonald PC, et al. Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis. J Med Chem 2011;54:1896–902
   PubMed Web of Science ®Google Scholar
• Pacchiano F, Aggarwal M, Avvaru BS, et al. Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency. Chem Commun 2010;46:8371–3
   PubMed Web of Science ®Google Scholar
• Celik F, Arslan M, Yavuz E, et al. Synthesis and carbonic anhydrase inhibitory properties of novel 1,4-dihydropyrimidinone substituted diarylureas. J Enzyme Inhib Med Chem 2014;29:18–22
   PubMed Web of Science ®Google Scholar
• Karatas MO, Alici B, Cakir U, et al. New coumarin derivatives as carbonic anhydrase inhibitors. Artif Cells Nanomed Biotechnol 2014;42:192–8
   PubMed Web of Science ®Google Scholar
• Karatas MO, Alici B, Cakir U, et al. Synthesis and carbonic anhydrase inhibitory properties of novel coumarin derivatives. J Enzyme Inhib Med Chem 2013;28:299–304
   PubMed Web of Science ®Google Scholar
• Celik F, Arslan M, Kaya MO, et al. Synthesis and carbonic anhydrase inhibitory properties of tetrazole- and oxadiazole substituted 1,4-dihydropyrimidinone compounds. Artif Cells Nanomed Biotechnol 2014;42:58–62
   PubMed Web of Science ®Google Scholar
• Sonmez F, Bilen C, Sumersan S, et al. In vitro inhibition effect and structure-activity relationships of some saccharin derivatives on erythrocyte carbonic anhydrase I and II. J Enzyme Inhib Med Chem 2014;29:118–23
   PubMed Web of Science ®Google Scholar
• Kuday H, Sonmez F, Bilen C, et al. Synthesis and in vitro inhibition effect of new pyrido[2,3-d]pyrimidine derivatives on erythrocyte carbonic anhydrase I and II. Biomed Res Int 2014;2014:594879
   PubMed Web of Science ®Google Scholar
• Kostava I. Synthetic and natural coumarins as antioxidants. Mini Rev Med Chem 2006;6:365–74
   PubMed Web of Science ®Google Scholar
• Göçer H, Akıncıoglu A, Öztaskın N, et al. Synthesis, antioxidant, and antiacetylcholinesterase activities of sulfonamide derivatives of dopamine-related compounds. Arch Pharm Chem Life Sci 2013;346:783–92
   PubMed Web of Science ®Google Scholar
• Geronikaki AA, Pitta EP, Liaras KS. Thiazoles and tthiazolidinones as antioxidants. Curr Med Chem 2013;20:4460–80
   PubMed Web of Science ®Google Scholar
• Ekinci D, Karagoz L, Ekinci D, et al. Carbonic anhydrase inhibitors: in vitro inhibition of α isoforms (hCA I, hCA II, bCA III, hCA IV) by flavonoids. J Enzyme Inhib Med Chem 2013;28:283–8
   PubMed Web of Science ®Google Scholar
• Innocenti A, Gülçin I, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I–XV. Bioorg Med Chem Lett 2010;20:5050–3
   PubMed Web of Science ®Google Scholar
• Sentürk M, Gülçin I, Dastan A, et al. Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols. Bioorg Med Chem 2009;17:3207–11
   PubMed Web of Science ®Google Scholar
• Sentürk M, Gülçin I, Beydemir S, et al. In vitro inhibition of human carbonic anhydrase I and II isozymes with natural phenolic compounds. Chem Biol Drug Des 2011;77:494–9
   PubMed Web of Science ®Google Scholar